Metallothionein content increased in the liver of mice exposed to magnetic fields

Archives of Toxicology

Volumn 70, Issue 5, 1996, Pages 315-318

  Satoh, M ^a   Tsuji, Y ^a   Watanabe, Y ^a   Okonogi, H ^a   Suzuki, Y ^a   Nakagawa, M ^b   Shimizu, H ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RAILWAY TECHNICAL RESEARCH INSTITUTE   (Japan)

Author keywords

Carbon tetrachloride; Liver; Metallothionein; Mice; Static magnetic fields

Indexed keywords

CARBON TETRACHLORIDE; METALLOTHIONEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; KIDNEY; LIVER; LIVER TOXICITY; MAGNETIC FIELD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; BRAIN CHEMISTRY; CARBON TETRACHLORIDE POISONING; ELECTROMAGNETIC FIELDS; ENZYME INDUCTION; KIDNEY; LIVER; MALE; METALLOTHIONEIN; MICE; MICE, INBRED BALB C; RATS;

EID: 0030020086     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050280     Document Type: Article

References (38)

1. Adey WR (1981) Tissue interaction with nonionizing electromagnetic fields. Physiol Rev 61: 435-514
2. Basu A, Lazo JS (1990) A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs. Toxicol Lett 50: 123-135
3. Bates MN (1991) Extremely low frequency electromagnetic fields and cancer: The epidemiological evidence. Environ Health Perspect 95: 147-156
4. Bauman JW, Liu J, Liu YP, Klaassen CD (1991) Increase in metallothionein produced by chemicals that induce oxidative stress. Toxicol Appl Pharmacol 110: 347-354
5. Brady FO (1982) The physiological function of metallothionein. Trends Biochem Sci 7: 143-145
6. Cousins RJ (1985) Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 65: 238-309
7. Endresen L, Bakka A, Rugstad HE (1983) Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Res 43: 2918-2926
8. Etzel KR, Shapiro SG, Cousins RJ (1979) Regulation of liver metallothionein and plasma zinc by the glucocorticoid dexamethasone. Biochem Biophys Res Commun 89: 1120-1126
9. Failla ML, Cousins RJ (1978) Zinc accumulation and metabolism in primary cultures of adult rat liver cells. Biochim Biophys Acta 543: 293-304
10. Feychting M, Ahlbom A (1993) Magnetic fields and cancer in children residing near Swedish high voltage power lines. Am J Epidemiol 138:467-481
11. Floderus B, Persson T, Stenlund C, Wennberg A, Ost A, Knave B (1993) Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors. A case-control study in Sweden. Cancer Causes Control 4: 465-476
12. Frankel RB (1986) Biological effects of static magnetic fields. In: Polk C, Postow E (eds) CRC handbook of biological effects of electromagnetic fields, CRC Press, Boca Raton, pp 180-181
13. 4: hepatic Zn-status and distribution of administered Cd. Toxicol Environ Chem 23: 73-78
14. Imura N, Satoh M, Naganuma A (1992) Possible application of melallothionein in cancer therapy. In: Klaassen CD, Suzuki KT (eds) Metallothionein in biology and medicine, CRC Press, Boca Raton, pp 375-382
15. Kagi JHR, Schaffer A (1988) Biochemistry of metallothionein. Biochemistry 27: 8509-8515
16. Karin M (1985) Metallothioneins: proteins in search of function. Cell 41: 9-10
17. Karin M, Herschman HR (1979) Dexamethasone stimulation of metallothionein synthesis in HeLa cell cultures. Science 204: 176-177
18. Kavaliers M, Ossenkopp K-P (1988) Day-night rhythms of opioid and non-opioid stress-induced analgesia: differential inhibitory effects of exposure to magnetic fields. Pain 32: 223-229
19. Kondo Y, Satoh M, Imura N, Akimoto M (1991) Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor. Cancer Chemother Pharmacol 29: 19-23
20. Kondo Y, Satoh M, Imura N, Akimoto M (1992) Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor. Anticancer Res 12: 2303-2308
21. Kotosonis FN, Klaassen CD (1977) Comparison of methods for estimating hepatic metallothionein in rats. Toxicol Appl Pharmacol 42: 583-588
22. London SJ, Thomas DC, Bowman JD, Sobel E, Cheng T-C, Peters JM (1991) Exposure to residential electric and magnetic fields and risk of childhood leukemia. Am J Epidemiol 134: 923-937
23. Min K-S, Terano Y, Onosaka S, Tanaka K (1992) Induction of metallothionein synthesis by menadione or carbon tetrachloride is independent of free radical production. Toxicol Appl Pharmacol 113: 74-79
24. Naganuma A, Satoh M, Imura N (1987) Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res 47: 983-987
25. Naganuma A, Satoh M, Imura N (1988) Specific reduction of toxic-side effects of adriamycin by induction of metallothionein in mice. Jpn J Cancer Res 79: 406-411
26. Nahas G, Boccalon H, Berryer P, Wagner B (1975) Effects in rodents of a one-month exposure to magnetic fields (200-1200 gauss). Aviat Space Environ Med 46: 1161-1163
27. Nakagawa M (1980) Food consumption of mice in the static magnetic fields of moderate strength. Jpn J Ind Health 22: 280-281
28. Oh SH, Deagen JT, Whanger PD, Weswig PH (1978) Biological function of metallothionein. V. Its induction in rats by various stresses. Am J Physiol 234: E282-E285
29. Ossenkopp K-P, Kavaliers M, Lipa S (1990) Increased mortality in land snails (Cepaea nemoralis) exposed to powerline (60-Hz) magnetic fields and effects of the light-dark cycle. Neurosci Lett 114: 89-94
30. Poyer LJ, Floyd AR, McCay BP, Janzen GE, Davis RE (1978) Spin-trapping of the trichloromethyl radical produced enzymic NADPH oxidation in the presence of carbon tetrachloride or bromotrichloromethane. Biochim Biophys Acta 539: 402-409
31. Sagan L (1992) Epidemiological and laboratory studies of power frequency electric and magnetic fields. JAMA 268: 625-629
32. Sato M, Bremner I (1993) Oxygen free radicals and metallothionein. Free Radic Biol Med 14: 325-337
33. Satoh M, Miura N, Naganuma A, Matsuzaki N, Kawamura E, Imura N (1989) Prevention of adverse effects of γ-ray irradiation by metallothionein induction by bismuth subnitrate in mice. Eur J Cancer Clin Oncol 25: 1727-1731
34. Satoh M, Tsuchiya T, Kumada Y, Naganuma A, Imura N (1993a) Protection against lethal toxicity of various anticancer drugs by preinduction of metallothionein synthesis in mice. J Trace Elem Exp Med 6: 41-44
35. Satoh M, Kloth DM, Kadhim SA, Chin JL, Naganuma A, Imura N, Cherian MG (1993b) Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res 53: 1829-1832
36. Satoh M, Cherian MG, Imura N, Shimizu H (1994) Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res 54: 5255-5257
37. Satomi N, Sakurai A, Haranaka R, Haranaka K (1988) Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factor. J Biol Response Mod 7: 54-64
38. Slater TF (1984) Free-radical mechanisms in tissue injury. Biochem J 222: 1-15